Table 3.
Distribution of Serious Drug-Related Adverse Events.*
Event | Earlier ART | Later ART number of events |
Total |
---|---|---|---|
Hepatic toxicity | 107 | 105 | 212 |
Anemia | 69 | 43 | 112 |
Mitochondrial toxicity | 16 | 19 | 35 |
Cutaneous toxicity | 10 | 22 | 32 |
Electrolyte disorders | 12 | 14 | 26 |
Metabolic disorders | 11 | 10 | 21 |
Neutropenia | 7 | 14 | 21 |
Peripheral neuropathy | 8 | 8 | 16 |
Gastrointestinal disorders | 3 | 6 | 9 |
Neuropsychiatric disorders | 6 | 1 | 7 |
Ocular toxicity | 1 | 2 | 3 |
Hypothyroidism | 0 | 1 | 1 |
Ototoxicity | 1 | 0 | 1 |
Total | 251 | 245 | 496 |
Serious adverse events were defined as those that were grade 3 or higher. Drugs included antiretroviral agents.